ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
New and emergent preparations for male hypogonadism treatment
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 269755" data-attributes="member: 13851"><p><strong>Article highlights</strong></p><p><strong></strong></p><p><strong><em>● Although the suggested cutoffs to start testosterone treatment, in symptomatic men, differ among available guidelines, the European position emphasized that 12 nM represents the best threshold.</em></strong></p><p><strong><em></em></strong></p><p><strong><em>● Preliminary results with nasal testosterone showing a minor effect on erythropoiesis, need to be confirmed.</em></strong></p><p><strong><em></em></strong></p><p><strong><em>● New oral formulations with self-emulsifying delivery systems have shown good results but these preparations are not available in Europe.</em></strong></p><p><strong><em></em></strong></p><p><strong><em>● Data related to developing preparations including kisspeptin or neurokinin-B agonists or IL1 antagonist are too preliminary.</em></strong></p><p><strong><em></em></strong></p><p><em><strong>● An accurate discussion with each individual patient on the advantages and disadvantages of each testosterone preparation, to allow a metered prescription is mandatory.</strong></em></p></blockquote><p></p>
[QUOTE="madman, post: 269755, member: 13851"] [B]Article highlights [I]● Although the suggested cutoffs to start testosterone treatment, in symptomatic men, differ among available guidelines, the European position emphasized that 12 nM represents the best threshold. ● Preliminary results with nasal testosterone showing a minor effect on erythropoiesis, need to be confirmed. ● New oral formulations with self-emulsifying delivery systems have shown good results but these preparations are not available in Europe. ● Data related to developing preparations including kisspeptin or neurokinin-B agonists or IL1 antagonist are too preliminary. [/I][/B] [I][B]● An accurate discussion with each individual patient on the advantages and disadvantages of each testosterone preparation, to allow a metered prescription is mandatory.[/B][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
New and emergent preparations for male hypogonadism treatment
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top